FIELD: medicine.
SUBSTANCE: invention refers to application of 17 alpha-acetate-21-pivaloat 17alpha, 21-dihydroxipregn-4-en-3.20 dion as an agent reducing pathological attraction to cocaine.
EFFECT: agent has high efficiency.
3 dwg, 2 ex
Title | Year | Author | Number |
---|---|---|---|
USING α-ACETATE-21-PYVALOATE-α,21-DIHYDROXYPREGN-4-ENE-3,20-DIONE AS ANTI-MORPHINE AGENT | 2005 |
|
RU2276981C1 |
DIHYDROXYPREGN-4-ENE-3,20-DIONE 17α-21-PIVALOATE ELICITING ANTIALCOHOLIC AND ANXIOLYTIC ACTIVITY | 1999 |
|
RU2171810C2 |
17ALPHA,21-DIHYDROXYPREGN-4-ENE-3,20-DIONE 17ALPHA,21-DIACETATE SHOWING ANTIALCOHOLIC AND ADAPTOGENIC ACTIVITY | 1999 |
|
RU2172173C2 |
STEROID ESTERS OR THEIR STEREOISOMERS, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION | 1992 |
|
RU2112775C1 |
22R- OR 22S-EPIMERS OF COMPOUNDS, METHOD OF PREPARATION THEREOF, PHARMACEUTICAL COMPOSITION, AND METHOD OF TREATING ALLERGIC AND INFLAMMATORY DISEASES | 1992 |
|
RU2111212C1 |
4-HETERO-16α, 17α-CYCLOHEXANOPREGNANES | 2009 |
|
RU2426737C1 |
CB1 RECEPTOR ANTAGONISTS | 2012 |
|
RU2593751C2 |
METHOD FOR PRODUCING 6-METHYLENEHYDROCORTISONE OR ESTERS THEREOF FROM HYDROCORTISONE 21-ACETATE | 2017 |
|
RU2664101C1 |
11,21-DIACETATE (22RS)-16α,17α-BUTYLIDENEDIOXY-1111β, 21-DIHYDROXYPREGNA-1,4-DIENE-3,20-DIONE AS INTERMEDIATE PRODUCT IN SYNTHESIS OF BUDECONIDE | 1989 |
|
SU1660379A1 |
METHOD OF PREPARATION 6α-METHYLHYDROCORTISONE OR ESTERS THEREOF FROM HYDROCORTISONE 21-ACETATE | 2017 |
|
RU2663484C1 |
Authors
Dates
2008-06-20—Published
2007-02-27—Filed